- Home
- GRCE vs POCI Comparison
GRCE vs POCI Comparison
Compare GRCE & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- POCI
- Stock Information
- Founded
- GRCE 2002
- POCI 1982
- Country
- GRCE United States
- POCI United States
- Employees
- GRCE N/A
- POCI N/A
- Industry
- GRCE
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GRCE
- POCI Health Care
- Exchange
- GRCE NYSE
- POCI Nasdaq
- Market Cap
- GRCE 40.0M
- POCI 32.4M
- IPO Year
- GRCE N/A
- POCI N/A
- Fundamental
- Price
- GRCE $3.00
- POCI $4.78
- Analyst Decision
- GRCE Strong Buy
- POCI
- Analyst Count
- GRCE 1
- POCI 0
- Target Price
- GRCE $12.00
- POCI N/A
- AVG Volume (30 Days)
- GRCE 40.7K
- POCI 13.9K
- Earning Date
- GRCE 08-15-2025
- POCI 05-15-2025
- Dividend Yield
- GRCE N/A
- POCI N/A
- EPS Growth
- GRCE N/A
- POCI N/A
- EPS
- GRCE N/A
- POCI N/A
- Revenue
- GRCE N/A
- POCI $17,626,155.00
- Revenue This Year
- GRCE N/A
- POCI N/A
- Revenue Next Year
- GRCE N/A
- POCI N/A
- P/E Ratio
- GRCE N/A
- POCI N/A
- Revenue Growth
- GRCE N/A
- POCI N/A
- 52 Week Low
- GRCE $1.75
- POCI $3.47
- 52 Week High
- GRCE $4.97
- POCI $6.59
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- POCI 56.46
- Support Level
- GRCE N/A
- POCI $4.47
- Resistance Level
- GRCE N/A
- POCI $4.80
- Average True Range (ATR)
- GRCE 0.00
- POCI 0.28
- MACD
- GRCE 0.00
- POCI 0.00
- Stochastic Oscillator
- GRCE 0.00
- POCI 85.11
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.